← Leaderboards
Swati P Deb
Virginia Commonwealth University
$961,946
Attributed
$1,303,104
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $682.3K · FY2023–24$1M$750K$500K$250K$0
'23
'24
Funding mix
By agency
NIH$1,303,104 · 3
By mechanism
R01$912,990 · 2
R21$390,114 · 1
Top collaborators
- Sumitra Deb1 shared
- Brad E. Windle1 shared
Most similar at Virginia Commonwealth University
Same institution · by research overlap
- Sumitra Deb$2,681,956
- Brad E. Windle$1,995,833
Others in their field
Top investigators on “Carcinogenesis”
- Thomas James Lynch · Fred Hutchinson Cancer Center$52,622,533
- John Anthony Baron · Dartmouth College$42,903,133
- Judith Cheryl Gasson · University Of California Los Angeles$27,647,316
- Walter C. Willett · Harvard University (Sch Of Public Hlth)$27,566,264
- Frank Louis Meyskens · University Of California Irvine$27,314,067
- Paul F Lambert · University Of Wisconsin Madison$25,295,170
Research focus
CarcinogenesisPropertyGain Of FunctionMutantNormal CellPhenotypeGene ExpressionLungMalignant Neoplasm Of LungMouse ModelCessation Of LifeCellsOncogenicPatient Derived Xenograft ModelLung Cancer CellCancer CellGenesGrowthLung NeoplasmsMutationMalignant NeoplasmsCell DeathAllelesSpecificity
Grant awards (5)
Novel inhibitors of oncogenic p53 mutants for lung cancer therapy.$172,376
R21 · FY2024 · CA · contact PI
Targeting lung tumors expressing mutant p53 with oncolytic viruses and suicide genes$464,578
R01 · FY2023 · CA
Novel inhibitors of oncogenic p53 mutants for lung cancer therapy.$217,738
R21 · FY2023 · CA · contact PI
OVEREXPRESSION OF MDM2 IN THE ETIOLOGY OF BREAST CANCER$229,081
R01 · FY2001 · CA
OVEREXPRESSION OF MDM2 IN THE ETIOLOGY OF BREAST CANCER$219,331
R01 · FY2000 · CA